Cutting the standard dose of Kaletra by 30 percent does not change its efficacy at suppressing HIV and it improves abnormal lipid levels among...

Two long-acting HIV meds maintained adequate blood levels and exhibited a promising safety profile when given to HIV-negative participants in...

HIV-negative gay men are much less likely to engage in unprotected intercourse with an positive partner if they perceive him to have a detecta...

One in 13 HIV-positive gay men who maintain an undetectable blood viral load still experience intermittent viral shedding in their semen.

American and Canadians with treated HIV enjoyed an increase in life expectancy of 15 years between periods of 2000 to 2002 and 2006 to 2007.

Pooled evidence shows that treating HIV when CD4 cells are at or above 350 is beneficial when compared with beginning therapy between 200 and...

People with HIV have a rate of end-stage renal disease (ESRD) more than five times that of the general population,

Offering lottery tickets to those who remained free of STI’s reduced by a third the number of new HIV infections among young women in Lesotho.

Sustiva (efavirenz) is both safe and just as effective at fighting HIV when the standard dose is reduced by a third.

Given to HIV-positive people who are treatment-experienced, the investigational integrase inhibitor dolutegravir has proved superior to Isentr...